STOCK TITAN

Equillium reported a $22.4M net loss for fiscal 2025. See the full EQ financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Equillium to Participate in Upcoming Investor Conferences

Equillium (EQ) will participate in two upcoming investor conferences in September 2026, featuring presentations and investor meetings.

(Moderate)
(Neutral)
Tags
conferences

Equillium (EQ) will participate in two upcoming investor conferences in September 2026, featuring presentations and investor meetings.

The company will join the Cantor Global Healthcare Conference 2026 on September 9, 2026 at 9:45 AM EDT via a fireside chat and 1x1 meetings, and the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 at 11:00 AM EDT with a company presentation and 1x1 meetings. A live webcast and 45-day replay of the Cantor fireside chat will be available through Equillium’s Investor Relations Events & Presentations page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Cantor Global Healthcare Conference 2026
Format: Fireside Chat & 1x1 Meetings
Date: Wednesday, September 9, 2026
Time: 9:45 AM EDT
Webcast Link: Here

H.C. Wainwright 28th Annual Global Investment Conference
Format: Company Presentation & 1x1 Meetings
Date: Monday, September 14, 2026
Time: 11:00 AM EDT

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.

About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com


FAQ

When will Equillium (EQ) present at the Cantor Global Healthcare Conference 2026?

Equillium is scheduled to participate in the Cantor Global Healthcare Conference 2026 on Wednesday, September 9, 2026, with a fireside chat starting at 9:45 AM EDT and 1x1 investor meetings.

How can investors access the Equillium (EQ) webcast for the Cantor Global Healthcare Conference 2026?

A live webcast of Equillium’s Cantor fireside chat will be available on the Events & Presentations page under the Investor Relations section of equilliumbio.com, with a replay accessible for about 45 days after the conference.

What is Equillium (EQ) doing at the H.C. Wainwright 28th Annual Global Investment Conference?

Equillium will deliver a company presentation and hold 1x1 meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, starting at 11:00 AM EDT.

Will Equillium (EQ) management be available for investor meetings at these September 2026 conferences?

Members of Equillium’s management team will be available for 1x1 meetings with investors who are registered to attend both the Cantor Global Healthcare Conference 2026 and the H.C. Wainwright 28th Annual Global Investment Conference.